Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The advent of highly active antiretroviral therapy (HAART) in 1996 led to a decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), but not of other cancers, among people with HIV or AIDS (PWHA). It also led to marked increases in their life expectancy. METHODS: We conducted a record-linkage study between the Swiss HIV Cohort Study and nine Swiss cantonal cancer registries. In total, 9429 PWHA provided 20,615, 17,690, and 15,410 person-years in the pre-, early-, and late-HAART periods, respectively. Standardised incidence ratios in PWHA vs the general population, as well as age-standardised, and age-specific incidence rates were computed for different periods. RESULTS: Incidence of KS and NHL decreased by several fold between the pre- and early-HAART periods, and additionally declined from the early- to the late-HAART period. Incidence of cancers of the anus, liver, non-melanomatous skin, and Hodgkin's lymphoma increased in the early- compared with the pre-HAART period, but not during the late-HAART period. The incidence of all non-AIDS-defining cancers (NADCs) combined was similar in all periods, and approximately double that in the general population. CONCLUSIONS: Increases in the incidence of selected NADCs after the introduction of HAART were largely accounted for by the ageing of PWHA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935 · cited 1×
“The effect of HIV-related immunodeficiency on cancers of the lung and liver remains, however, ill-defined (Bouvard et al, 2009).”
BackgroundThompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
Hammer, S. M., Eron, J. J., Reiss, P., Schooley, R. T., Thompson, M. A., Walmsley, S., Cahn, P., Fischl, M. A., Gatell, J. M., Hirsch, M. S., et al. (2008) · JAMA · doi:10.1001/jama.300.5.555 · Cited by 1,026
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Self-citationStatistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Cancer risk in people infected with human immunodeficiency virus in the United States
Engels, E. A., Biggar, R. J., Hall, H. I., Cross, H., Crutchfield, A., Finch, J. L., Grigg, R., Hylton, T., Pawlish, K. S., McNeel, T. S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23487 · Cited by 768
Guiguet, M., Boué, F., Cadranel, J., Lang, J.-M., Rosenthal, E., & Costagliola, D. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70282-7 · Cited by 571
Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDS
Chaturvedi, A. K., Madeleine, M. M., Biggar, R. J., & Engels, E. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp205 · Cited by 523
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking
Kirk, G. D., Merlo, C., O'Driscoll, P., Mehta, S. H., Galai, N., Vlahov, D., Samet, J., & Engels, E. A. (2007) · Clinical Infectious Diseases · doi:10.1086/518606 · Cited by 387
Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Mandelia, S., Møller, H., & Bower, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6626 · Cited by 360
Cohort Profile: The Swiss HIV Cohort Study
Study, T. S. H. C., Schoeni-Affolter, F., Ledergerber, B., Rickenbach, M., Rudin, C., Gunthard, H. F., Telenti, A., Furrer, H., Yerly, S., & Francioli, P. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp321 · Cited by 346
Self-citationPiketty, C., Selinger-Leneman, H., Grabar, S., Duvivier, C., Bonmarchand, M., Abramowitz, L., Costagliola, D., & Mary-Krause, M. (2008) · AIDS · doi:10.1097/qad.0b013e3283023f78 · Cited by 280
Puoti, M., Bruno, R., Soriano, V., Donato, F., Gaeta, G. B., Quinzan, G. P., Precone, D., Gelatti, U., Asensi, V., & Vaccher, E. (2004) · AIDS · doi:10.1097/00002030-200411190-00009 · Cited by 249
Ledergerber, B., Telenti, A., & Egger, M. (1999) · BMJ · doi:10.1136/bmj.319.7201.23 · Cited by 247
Self-citationInfluence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
Clifford, G. M., Rickenbach, M., Polesel, J., Dal Maso, L., Steffen, I., Ledergerber, B., Rauch, A., Probst-Hensch, N. M., Bouchardy, C., Levi, F., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32831103ad · Cited by 169
Self-citationStudy, A. T. S. H. C., Franceschi, S., Maso, L. D., Rickenbach, M., Polesel, J., Hirschel, B., Cavassini, M., Bordoni, A., Elzi, L., Ess, S., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604520 · Cited by 168
Self-citationElevated risk of lung cancer among people with AIDS
Chaturvedi, A. K., Pfeiffer, R. M., Chang, L., Goedert, J. J., Biggar, R. J., & Engels, E. A. (2007) · AIDS · doi:10.1097/qad.0b013e3280118fca · Cited by 166
Pattern of cancer risk in persons with AIDS in Italy in the HAART era
Study, F. T. C. A. A. R. L. (., Dal Maso, L., Polesel, J., Serraino, D., Lise, M., Piselli, P., Falcini, F., Russo, A., Intrieri, T., Vercelli, M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604923 · Cited by 165
Self-citationPolesel, J., Clifford, G. M., Rickenbach, M., Maso, L. D., Battegay, M., Bouchardy, C., Furrer, H., Hasse, B. K., Levi, F., Probst-Hensch, N. M., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282f2705d · Cited by 152
Self-citationHIV-related lung cancer in the era of highly active antiretroviral therapy
Bower, M., Powles, T., Nelson, M. R., Shah, P. L., Cox, S., Mandelia, S., & Gazzard, B. (2003) · AIDS · doi:10.1097/00002030-200302140-00011 · Cited by 149
Rosenthal, É., Pialoux, G., Bernard, N., Pradier, C., Rey, D., Bentata, M., Michelet, C., Pol, S., Perronne, C., Cacoub, P., et al. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00791.x · Cited by 137
Antitumour effects of antiretroviral therapy
Monini, P., Sgadari, C., Toschi, E., Barillari, G., & Ensoli, B. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1479 · Cited by 135
Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States
Lanoy, É., Dores, G. M., Madeleine, M. M., Toro, J. R., Fraumeni, J. F., & Engels, E. A. (2009) · AIDS · doi:10.1097/qad.0b013e3283213046 · Cited by 134
van Leeuwen, M. T., Vajdic, C. M., Middleton, M., McDonald, A. M., Law, M. G., Kaldor, J. M., & Grulich, A. E. (2009) · AIDS · doi:10.1097/qad.0b013e328331d384 · Cited by 127
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors
Olivero, O. A. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20195 · Cited by 115
Vo, T. T. N., Ledergerber, B., Keiser, O., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/588141 · Cited by 108
Self-citationKeiser, O., Taffé, P., Zwahlen, M., Battegay, M., Bernasconi, E., Weber, R. K., & Rickenbach, M. (2004) · AIDS · doi:10.1097/00002030-200409030-00013 · Cited by 89
Self-citationCancer incidence in people with AIDS in Italy
Polesel, J., Franceschi, S., Suligoi, B., Crocetti, E., Falcini, F., Guzzinati, S., Vercelli, M., Zanetti, R., Tagliabue, G., Russo, A. G., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25153 · Cited by 68
Self-citation
Cited by
Machalek, D. A., Poynten, M., Jin, F., Fairley, C. K., Farnsworth, A., Garland, S. M., Hillman, R. J., Petoumenos, K., Roberts, J., Tabrizi, S. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70080-3 · Cited by 963
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Hernández-Ramírez, R. U., Shiels, M. S., Dubrow, R., & Engels, E. A. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30125-x · Cited by 507
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463
Self-citationWing, E. J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.004 · Cited by 287
Metadata
- Authors
- Study, T. S. H. C., Franceschi, S., Lise, M., Clifford, G. M., Rickenbach, M., Levi, F., Maspoli, M., Bouchardy, C., Dehler, S., Jundt, G., Ess, S., Bordoni, A., Konzelmann, I., Frick, H., Dal Maso, L., Elzi, L., Furrer, H., Calmy, A., Cavassini, M., Ledergerber, B., & Keiser, O.
- Venue
- British Journal of Cancer
- Published
- 2010-06-29
- Volume
- 103
- Issue
- 3
- Pages
- 416-422
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2043223046
- Cited by
- 307
- References
- 39
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.